| Literature DB >> 29211280 |
Ana Elisa de Mello Vieira1, Marcelle Danelon1, Danielle Mendes da Camara1, Eliana Rodrigues Rosselli1, Stuart R Stock2, Mark L Cannon3, Xianghui Xiao4, Francesco De Carlo4, Alberto Carlos Botazzo Delbem1.
Abstract
OBJECTIVES: Dental applications based on the unique characteristics of amorphous calcium phosphate stabilized by casein phosphopeptides (CPP-ACP) have been proposed, as well as the improvement of its properties. The objective of this study was to determine the ability of topically applied CPP-ACP from a commercial product to remineralize subsurface lesions when applied for extended periods of time (3 h and 8 h).Entities:
Mesh:
Substances:
Year: 2017 PMID: 29211280 PMCID: PMC5701529 DOI: 10.1590/1678-7757-2016-0513
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Mean values (SD) of hardness (n=10) and synchrotron (n=6) enamel analysis according to the treatments
| Treatments | Variables | |||
|---|---|---|---|---|
| SH2 (KHN) | %SHR | IML (gHAp.cm−3 x μm) | Lesion Depth (μm) | |
| Placebo | 115.8a | 18.1a | -13.1a | 82.6a |
| (32.6) | (5.1) | (4.4) | (5.8) | |
| Fluoride 1 min | 200.6b | 46.4b | -1.4b | 40.1b |
| (21.2) | (4.4) | (0.9) | (9.6) | |
| ACP 3 min | 143.1c | 25.3c | -4.3c | 41.1b |
| (23.9) | (4.6) | (15) | (2.3) | |
| ACP 3 h | 102.1a | 13.3a | -17.5e | 78.4a |
| (34.9) | (7.1) | (3.1) | (13.5) | |
| ACP 8 h | 107.7a | 14.1a | -11.3a | 72.8a |
| (23.6) | (4.7) | (5.2) | (8.7) | |
Lowercase letters indicate statistically significant differences (Student-Newman-Keuls; p<0.05) between the groups in each analysis.
SH2=surface hardness after pH-cycling.
%SHR=percentage of surface hardness recovery.
IML=integrated loss of subsurface mineral.
Figure 1Depth profiles of mineral concentration (gHAp.cm−3) in lesions for each treatment, (a) Comparison of mineral profiles from Placebo, Fluoride 1 min and ACP 3 min groups, (b) Mineral profiles from Placebo, ACP 3 h and ACP 8 h. (c) Mineral profiles from Placebo, ACP 3 min, ACP 3 h and ACP 8 h. (d) Differential mineral concentration profiles as a function of depth according to the treatments: zone A: 2.8-16.8 μm and zone B: 19.6-33.6 μm. *: maximum mineral concentration on outer enamel layer. ★: maximum mineral concentration through the lesion for each group. A: subsurface lesion. ↓: lamination
Figure 2Synchrotron micro-computed tomography (SMCT) slice from a typical specimen of the (a) placebo and (b) ACP 8 h group. The lighter the voxel, the higher the mineral concentration. The dentino-enamel junction is labeled DEJ
Mean values (SD) of integrated of differential profiles (ΔIML) calculated for two zones (Figure 1d) in the enamel lesions according to the treatments
| Treatments | ΔIML (gHAp.cm−3 x μm) | |
|---|---|---|
| zone A (2.8-16.8 μm) | zone B (19.6-33.6 μm) | |
| Fluoride 1 min | 6.24a,A | 1.60a,B |
| (0.69) | (0.40) | |
| ACP 3 min | 3.56b,A | 2.11a,B |
| (0.79) | (0.61) | |
| ACP 3 h | 0.08d,A | -3.50b,B |
| (143) | (166) | |
| ACP 8 h | 1.71c,A | -1.59c,B |
| (2.29) | (2.47) | |
Lowercase letters indicate statistically significant differences between the groups in each zone. Capital letters indicate the differences between zone A and zone B for each treatment (Student-Newman-Keuls; p<0.05).